Immediate emergency medical attention by calling 999 or attending Accident and Emergency is warranted if you experience severe or concerning symptoms
Important Safety Information What is the most important information I should know about Wegovy
After four weeks your dosage will gradually increase until you reach the maintenance dose of 2.4 mg per week
These adults were given either 2.4mg of semaglutide (Wegovy) weekly or a placebo for an average of about three years
Current and resolved drug shortages and discontinuations reported to FDA, Food and Drug Administration (2024) Bydureon BCise highlights of prescribing information, Food and Drug Administration (2022) Ozempic highlights of prescribing information, Food and Drug Administration (2023) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with Type 2 diabetes (Sustain 3): A 56-week, open-label, randomized clinical trial, Diabetes Care (2018) Label: Bydureon BCise, DailyMed (2023) Label: Ozempic, Daily Med (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: A systematic review, Drug Safety (2024) The clinical efficacy and safety of glucagon-like peptide-1 (GLP-1) Agonists in adults with Type 2 diabetes mellitus, Clinical Medicine Insights: Endocrinology and Diabetes (2011) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
